Cellebrite DI Ltd. (NASDAQ: CLBT)

$14.15 ▲ +0.05 (+0.35%)

As of Apr 07, 2026 04:00 PM

Sector: Technology Industry: Software - Infrastructure CIK: 0001854587

Market Cap 3.50 Bn

P/E 43.75

P/S 7.11

Div. Yield 0.00

Add ratio to table...

About

Cellebrite DI Ltd., known by its ticker symbol CLBT, is a prominent player in the digital investigative solutions industry. The company's offerings are primarily software and services-based, assisting public and private sector customers worldwide in transforming their investigative workflows and making digital evidence more accessible, actionable, and defensible. Cellebrite's business activities revolve around providing a wide range of digital investigative solutions. These solutions are used by approximately 7,000 customers globally, many of which...

Cellebrite DI Ltd., known by its ticker symbol CLBT, is a prominent player in the digital investigative solutions industry. The company's offerings are primarily software and services-based, assisting public and private sector customers worldwide in transforming their investigative workflows and making digital evidence more accessible, actionable, and defensible.

Cellebrite's business activities revolve around providing a wide range of digital investigative solutions. These solutions are used by approximately 7,000 customers globally, many of which are large federal, state, and local law enforcement and government agencies, as well as enterprise companies and service providers. The company's operations span across various regions, including North America, Europe, Asia, Africa, and Latin America.

The company's revenue is generated through the sale of digital forensic software, case and evidence management, and investigative analytic solutions to its diverse customer base. Its primary digital forensic software offering, Inseyets, is an integrated solution that delivers lawful access to a broad range of digital sources, provides comprehensive data extraction, faster decoding capabilities, intuitive workflows, and advanced automation capabilities. This product is specifically designed to aid law enforcement agencies of all sizes in completing device examinations faster, thereby supporting their efforts to expedite investigations and reduce device backlog.

Cellebrite's position within the industry is solidified by its diverse customer base and comprehensive suite of digital investigative solutions. The company's competitive advantages include its broad range of digital forensic software offerings, its ability to provide lawful access to digital sources, and its advanced automation capabilities.

The company's customer base is approximately 7,000 public and private sector organizations, including federal, state, and local law enforcement agencies, government agencies, enterprise companies, and service providers. These customers are spread across various regions, including North America, Europe, Asia, Africa, and Latin America.

In terms of its product portfolio, Cellebrite offers a range of digital investigative solutions under different segments. The Digital Forensics Units segment, the C2C Platform, and the Investigative Units segment all provide comprehensive suites of digital investigative solutions. These solutions include digital forensics software, case and evidence management, and investigative analytics tools, enabling users to collect, review, analyze, and manage digital evidence from a wide range of digital sources. The Private Sector segment, on the other hand, is designed to help enterprise companies and service providers investigate crimes, track down suspects, and solve cases more efficiently and effectively.

Investment thesis

Bull case

Cellebrite’s annual recurring revenue momentum is unmistakably robust, with a 21 % year‑over‑year increase that outpaces many peers in the digital forensics niche. The headline growth is underpinned by a 17 % organic lift, signalling that core demand for investigative analytics remains strong even after the dilution from a sizeable federal flat‑growth quarter. This organic surge is a clear indicator that the company’s flagship offerings—Pathfinder, Guardian, and the newly acquired Keryllium—are capturing significant share of the market, and the expectation that these solutions will approach a 20 % slice of ARR by year‑end points to a sustainable product mix shift. A 21 % increase in installed base conversion to Insights (55 % versus a 50 % target) further validates that customers see tangible value in the upgrade, which typically drives higher pricing and longer retention.
The firm’s strategic expansion into the cloud is a pivotal catalyst, with SaaS and cloud‑based ARR growing over 50 % and now representing 22 % of total ARR. This transition to a recurring revenue model aligns with broader industry trends toward subscription‑based licensing, reducing churn risk and smoothing cash flows. The company’s focus on cloud security, evidenced by the imminent FedRAMP Level 4 ATO, unlocks an entire segment of federal agencies that require secure evidence hosting, thereby creating a high‑barrier, high‑margin opportunity that could propel federal ARR growth beyond the 19 % trajectory forecast for the full year. The convergence of cloud adoption and federal demand positions the company to capture a rapidly expanding TAM that is not yet saturated by competitors.
Acquisition of Keryllium in December not only broadened the product portfolio with unique ARM virtualization technology but also demonstrated the company’s willingness to invest in disruptive capabilities that are difficult for rivals to replicate. Management’s assertion that Keryllium “exceeded expectations” in customer interest suggests early traction that could accelerate beyond the conservative headwinds mentioned in the guidance. The integration costs are viewed as transient, with CFO Barter projecting margin recovery by year‑end, implying that the long‑term profitability impact will be limited to a short‑term bump in operating expenses. Should Keryllium continue to deliver on its integration promise, it could become a new high‑growth engine that feeds into cross‑sell opportunities with existing Guardian and Pathfinder customers.
The pending SCG Canada acquisition introduces drone forensic extraction capabilities, a nascent yet high‑growth area projected to exceed $53 billion by 2026. While the deal is small in terms of current ARR, the TAM for drone‑related evidence is expanding rapidly, and the company’s existing forensic expertise positions it to be a first‑mover in this vertical. The strategic rationale is clear: extending the platform to another sensor type diversifies the data sources available to investigators, increasing the stickiness of the platform and reducing the risk of customer churn. Moreover, the acquisition’s low valuation ($15‑20 million) suggests a high upside if the company can monetize the new capability in line with its broader subscription strategy.
A pronounced focus on AI, both internal productivity tools and customer‑facing applications such as AgenTeq, signals a potential new revenue stream that is currently under the radar of the guidance. By embedding AI into the core product line, the firm could unlock higher value per user and reduce manual investigative labor costs for customers, which may justify premium pricing. The CEO’s candid remarks that monetization of AI features is likely to surface in 2026 imply that future earnings guidance could be understated, offering upside potential once the company fully capitalizes on this capability. Furthermore, the AI enhancements dovetail with the company’s mission to “speed up investigations,” reinforcing its differentiation from competitors that have slower data processing capabilities.

Cellebrite’s annual recurring revenue momentum is unmistakably robust, with a 21 % year‑over‑year increase that outpaces many peers in the digital forensics niche. The headline growth is underpinned by a 17 % organic lift, signalling that core demand for investigative analytics remains strong even after the dilution from a sizeable federal flat‑growth quarter. This organic surge is a clear indicator that the company’s flagship offerings—Pathfinder, Guardian, and the newly acquired Keryllium—are capturing significant share of the market, and the expectation that these solutions will approach a 20 % slice of ARR by year‑end points to a sustainable product mix shift. A 21 % increase in installed base conversion to Insights (55 % versus a 50 % target) further validates that customers see tangible value in the upgrade, which typically drives higher pricing and longer retention.
The firm’s strategic expansion into the cloud is a pivotal catalyst, with SaaS and cloud‑based ARR growing over 50 % and now representing 22 % of total ARR. This transition to a recurring revenue model aligns with broader industry trends toward subscription‑based licensing, reducing churn risk and smoothing cash flows. The company’s focus on cloud security, evidenced by the imminent FedRAMP Level 4 ATO, unlocks an entire segment of federal agencies that require secure evidence hosting, thereby creating a high‑barrier, high‑margin opportunity that could propel federal ARR growth beyond the 19 % trajectory forecast for the full year. The convergence of cloud adoption and federal demand positions the company to capture a rapidly expanding TAM that is not yet saturated by competitors.
Acquisition of Keryllium in December not only broadened the product portfolio with unique ARM virtualization technology but also demonstrated the company’s willingness to invest in disruptive capabilities that are difficult for rivals to replicate. Management’s assertion that Keryllium “exceeded expectations” in customer interest suggests early traction that could accelerate beyond the conservative headwinds mentioned in the guidance. The integration costs are viewed as transient, with CFO Barter projecting margin recovery by year‑end, implying that the long‑term profitability impact will be limited to a short‑term bump in operating expenses. Should Keryllium continue to deliver on its integration promise, it could become a new high‑growth engine that feeds into cross‑sell opportunities with existing Guardian and Pathfinder customers.
The pending SCG Canada acquisition introduces drone forensic extraction capabilities, a nascent yet high‑growth area projected to exceed $53 billion by 2026. While the deal is small in terms of current ARR, the TAM for drone‑related evidence is expanding rapidly, and the company’s existing forensic expertise positions it to be a first‑mover in this vertical. The strategic rationale is clear: extending the platform to another sensor type diversifies the data sources available to investigators, increasing the stickiness of the platform and reducing the risk of customer churn. Moreover, the acquisition’s low valuation ($15‑20 million) suggests a high upside if the company can monetize the new capability in line with its broader subscription strategy.
A pronounced focus on AI, both internal productivity tools and customer‑facing applications such as AgenTeq, signals a potential new revenue stream that is currently under the radar of the guidance. By embedding AI into the core product line, the firm could unlock higher value per user and reduce manual investigative labor costs for customers, which may justify premium pricing. The CEO’s candid remarks that monetization of AI features is likely to surface in 2026 imply that future earnings guidance could be understated, offering upside potential once the company fully capitalizes on this capability. Furthermore, the AI enhancements dovetail with the company’s mission to “speed up investigations,” reinforcing its differentiation from competitors that have slower data processing capabilities.

Bear case

The company’s recent free‑cash‑flow margin compression, primarily due to the strengthening shekel and Keryllium integration costs, signals an impending pressure on profitability that could persist longer than anticipated. While management labels the FX impact as transitory, the shekel has strengthened by more than a point, and the cost absorption from Keryllium is projected to last until year‑end, potentially eroding the 26 % adjusted EBITDA margin forecasted for 2026. If the headwinds persist, the company may be forced to further tighten margins or reduce growth‑driven spend, which could stall the expansion of its cloud and AI initiatives.
The reliance on the U.S. federal segment as a growth engine carries a hidden risk: the company’s revenue from that segment grew flat in 2025 and is contingent on securing a FedRAMP Level 4 ATO, a regulatory milestone that has proven protracted and costly. The company’s narrative of an imminent ATO could be overly optimistic, and any delay would stall a key revenue driver that is projected to exceed overall company growth in 2026. A setback in federal compliance could also trigger a loss of confidence among federal customers, leading to churn and a lower renewal rate than projected.
Acquisition execution risk is evident in the SCG Canada deal, which, while strategically appealing, remains in the conditional approval stage and carries integration uncertainty. The company’s own admission that the deal’s ARR contribution is “low single‑digit millions” suggests a limited immediate impact; if integration falters or the expected demand for drone forensics underperforms, the investment could become a drain rather than a growth engine. The fact that the acquisition is still awaiting completion by the end of Q1 adds uncertainty to the company’s capital allocation and could strain cash flows if additional working‑capital requirements arise.
While the company highlights its AI roadmap, it admits that current monetization of AI‑driven applications is not yet reflected in the guidance. This presents a risk that the company may over‑estimate the eventual revenue lift from AI, especially given the high barriers to building trustworthy, regulated AI tools in the forensic space. Any misalignment between the expected AI uptake and actual customer adoption could leave the company with an under‑priced valuation relative to the potential upside that investors anticipate.
The aggressive salesforce expansion—approximately 20 % increase in sales executives—could strain the company’s operating leverage if the incremental hires fail to generate proportional revenue. The company’s guidance presumes a smooth scaling of sales effectiveness, yet the rapid headcount growth might lead to internal inefficiencies, higher training costs, and potential dilution of sales focus across a broader customer base. If these investments do not translate into the projected 18‑19 % ARR growth, the firm may face a shortfall in top‑line expectations and pressure on margins as the sales costs remain elevated.

The company’s recent free‑cash‑flow margin compression, primarily due to the strengthening shekel and Keryllium integration costs, signals an impending pressure on profitability that could persist longer than anticipated. While management labels the FX impact as transitory, the shekel has strengthened by more than a point, and the cost absorption from Keryllium is projected to last until year‑end, potentially eroding the 26 % adjusted EBITDA margin forecasted for 2026. If the headwinds persist, the company may be forced to further tighten margins or reduce growth‑driven spend, which could stall the expansion of its cloud and AI initiatives.
The reliance on the U.S. federal segment as a growth engine carries a hidden risk: the company’s revenue from that segment grew flat in 2025 and is contingent on securing a FedRAMP Level 4 ATO, a regulatory milestone that has proven protracted and costly. The company’s narrative of an imminent ATO could be overly optimistic, and any delay would stall a key revenue driver that is projected to exceed overall company growth in 2026. A setback in federal compliance could also trigger a loss of confidence among federal customers, leading to churn and a lower renewal rate than projected.
Acquisition execution risk is evident in the SCG Canada deal, which, while strategically appealing, remains in the conditional approval stage and carries integration uncertainty. The company’s own admission that the deal’s ARR contribution is “low single‑digit millions” suggests a limited immediate impact; if integration falters or the expected demand for drone forensics underperforms, the investment could become a drain rather than a growth engine. The fact that the acquisition is still awaiting completion by the end of Q1 adds uncertainty to the company’s capital allocation and could strain cash flows if additional working‑capital requirements arise.
While the company highlights its AI roadmap, it admits that current monetization of AI‑driven applications is not yet reflected in the guidance. This presents a risk that the company may over‑estimate the eventual revenue lift from AI, especially given the high barriers to building trustworthy, regulated AI tools in the forensic space. Any misalignment between the expected AI uptake and actual customer adoption could leave the company with an under‑priced valuation relative to the potential upside that investors anticipate.
The aggressive salesforce expansion—approximately 20 % increase in sales executives—could strain the company’s operating leverage if the incremental hires fail to generate proportional revenue. The company’s guidance presumes a smooth scaling of sales effectiveness, yet the rapid headcount growth might lead to internal inefficiencies, higher training costs, and potential dilution of sales focus across a broader customer base. If these investments do not translate into the projected 18‑19 % ARR growth, the firm may face a shortfall in top‑line expectations and pressure on margins as the sales costs remain elevated.

Product and Service Breakdown of Revenue (2025)

Peer comparison

Companies in the Software - Infrastructure

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	MSFT	Microsoft Corp	2,762.99 Bn	23.17	9.05	40.26 Bn
2	ORCL	Oracle Corp	410.98 Bn	25.12	6.41	124.72 Bn
3	PLTR	Palantir Technologies Inc.	358.70 Bn	217.41	80.15	-
4	MDB	MongoDB, Inc.	201.71 Bn	-292.00	81.87	-
5	PANW	Palo Alto Networks Inc	119.05 Bn	90.56	12.03	-
6	CRWD	CrowdStrike Holdings, Inc.	106.96 Bn	-649.48	22.23	0.75 Bn
7	VRSN	Verisign Inc/Ca	97.79 Bn	31.14	59.03	1.79 Bn
8	SNPS	Synopsys Inc	76.17 Bn	60.47	9.51	10.04 Bn

Research Tools